Quantcast

Latest Amnion Stories

2014-10-16 12:29:34

EpiFix® shown to result in the most rapid improvement and resolution of DFUs, successful complex management of extensive life-threatening wounds, and safe and effective treatment of Stage IV Pressure Ulcers MARIETTA, Ga., Oct. 16, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG) EpiFix® dehydrated human amnion/chorion membrane (dHACM) allografts have been shown to be clinically effective in the treatment of hard-to-heal wounds such as diabetic foot ulcers (DFUs), pressure ulcers...

2014-09-30 16:28:42

MARIETTA, Ga., Sept. 30, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that Dr. Tom Koob, Ph.D., Chief Scientific Officer, will present at the Stem Cell Meeting on the Mesa. Dr. Koob will...

2014-09-03 12:24:59

Study determines allografts with both amnion and chorion contain approximately 20 times more cytokines than the competitive single layer amnion allografts evaluated MARIETTA, Ga., Sept. 3, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today the publication of another peer-reviewed scientific study in the scientific...

2014-04-29 16:32:03

Company Amends its Patent Infringement Lawsuit to Include Two Additional Patents MARIETTA, Ga., April 29, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its receipt of four newly issued patents related to the Company's tissue allografts derived from the placenta. On April 22, 2014, the U.S. Patent and...

2014-04-28 12:30:43

EDISON, N.J., April 28, 2014 /PRNewswire/ -- The Musculoskeletal Transplant Foundation (MTF) has been notified that on April 21, 2014, MiMedx Group, Inc. (MiMedx) filed a complaint in the United States District Court for the Northern District of Georgia, naming MTF, together with Liventa Bioscience, Inc. and Medline Industries Inc., as defendants. The complaint alleges patent infringement by MTF of four MiMedx patents. MTF does not believe it infringes any of the patents and is...

2014-04-23 12:29:55

EpiFix® is shown to promote rapid healing and return to function for patients and provide a potential for significant cost savings. MARIETTA, Ga., April 23, 2014 /PRNewswire/ -- EpiFix®, dehydrated human amnion/chorion membrane (dHACM) allografts, were shown to be clinically and cost effective in the treatment of multiple hard-to-treat wounds like diabetic foot ulcers (DFUs), venous leg ulcers (VLUs), and pressure ulcers (PUs), according to data and case experiences being presented at the...

2014-04-22 08:33:34

MARIETTA, Ga., April 22, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc. ("Liventa"), Medline Industries, Inc. ("Medline") and Musculoskeletal Transplant Foundation, Inc. ("MTF") for permanent injunctive relief and unspecified...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related